CQuentia Offers Testing for Covid-19
CQuentia’s covid-19 assay has received FDA emergency use authorization, and its lab has the capacity to process more than 20,000 samples per month.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
CQuentia’s covid-19 assay has received FDA emergency use authorization, and its lab has the capacity to process more than 20,000 samples per month.
Read MorePosted by | Apr 14, 2020 | Coagulation Testing, Hematology & Serology, Hematology Instrumentation, POC Instruments, POC Rapid Assays, POC Reagents & Test Kits, Point-of-Care |
The Allegro and its StatStrip-A companion meter now provide 18 tests to help physicians make therapeutic decisions and adjustments at the point of care.
Read MorePosted by | Apr 2, 2020 | Blood Gas Analyzers, Clinical Chemistry, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Already available in countries requiring the CE mark, the RapidPoint 500e blood gas analyzer is now available for critical care testing in the United States.
Read MorePosted by | Apr 2, 2020 | POC Instruments, POC Rapid Assays, POC Reagents & Test Kits, Point-of-Care |
The FDA CLIA-waived handheld analyzer reliably and efficiently delivers results within just 5 to 10 seconds, and it can be used in point-of-care (POC) and certificate of waiver settings, such as physicians’ offices, clinics, and other nontraditional laboratory locations.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read More